HanchorBio Inc. (TPEX:7827)
68.10
+1.30 (1.95%)
At close: Nov 21, 2025
HanchorBio Company Description
HanchorBio Inc. operates as a biotechnology company that develops biologics for cancer patients.
The company offers FBDB platform to develop biological medicines. The company also engages in novel target research and evaluation, development of in vitro and in vivo models for evaluating the bioactivities of anti-cancer drugs, and development of proteins.
HanchorBio Inc. was founded in 2020 and is based in Taipei, Taiwan with an additional office in Shanghai, China.
HanchorBio Inc.
| Country | Cayman Islands |
| Founded | 2020 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Shi-Kau Liu |
Contact Details
Address: 5F-1, No. 1 Taipei, 11493 Taiwan | |
| Phone | 886 2 2792 1366 |
| Website | hanchorbio.com |
Stock Details
| Ticker Symbol | 7827 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Shi-Kau Liu | Chief Executive Officer |